FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sumatriptan (ZECUITY®) Iontophoretic Transdermal System
Status: Discontinuation
»Therapeutic Categories: Neurology

Teva Pharmaceuticals (New 10/19/2017)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
ZECUITY® (NDC 51759-101-04) (Carton of 4 Patches) ZECUITY® (NDC 51759-101-01) (Single Patch) ZECUITY® (NDC 51759-101-00) (Carton of 4 Patches) 10/19/2017 Product manufacture has been discontinued and it is no longer available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English